Melanoma & Skin Cancer Advocacy Network (MSCAN) is an innovative, consumer-led, independent, national charity established to address the needs of Australians with a skin cancer diagnosis and to deliver policy reform that will help shape the way skin cancer is considered and managed in this country.
Read MSCAN’s blog with Melanoma and Skin Cancer Trials CEO, Gabrielle Byars, to learn about clinical trials for melanoma and skin cancer patients.
Listen to MSCAN’s podcast featuring Melanoma and Skin Cancer Trials Board Chair, Prof Mark Shackleton, talking about what a clinical trial is, how they are developed and why they are so important.